Shanghai Reinovax Biologics Co.,ltd

This study tests a new vaccine (RZ700) designed to protect infants and young children (ages 6 weeks to 71 months) against 24 types of pneumococcal bacteria, which can cause pneumonia and other serious infections. The trial will check how well the vaccine triggers an immune respon…